Our study showed that PD-L1 (clone 22C3) is more highly expressed in normal tissue adjacent to the tumor than intratumoral tissue, revealing that this is not the main mechanism of lymphocyte inactivation in MTC and is therefore not a good way to treat patients. The gene discussed is CD274; the disease is medullary thyroid gland carcinoma.